Literature DB >> 10327907

Panic disorder subtypes: differential responses to CO2 challenge.

B Biber1, T Alkin.   

Abstract

OBJECTIVE: The purpose of this study was to investigate the possibility of a differential sensitivity to CO2 in patients diagnosed with panic disorder subtypes that were defined by the presence of prominent respiratory symptoms.
METHOD: The authors used a 35% CO2 and 65% O2 mixture as a challenge agent. Fifty-one unmedicated subjects with DSM-III-R panic disorder, who were divided into respiratory (N = 28) and nonrespiratory (N = 23) subtypes by their symptom profiles, underwent a CO2 challenge procedure. Patients in the two groups were compared with regard to physiological and psychological measures, pulmonary function tests, panic rates, and smoking habits.
RESULTS: The patients in the respiratory group were significantly more sensitive to CO2 than were the patients in the nonrespiratory group. The respiratory group also had higher scores on the Panic and Agoraphobia Scale and had a longer duration of illness; both of these factors can be indicators of illness severity. In addition, the respiratory group's higher cigarette consumption (mean = 12.46 package-years, SD = 2.49) may have been a contributory factor not only for illness severity but also for the pathogenesis of panic disorder.
CONCLUSIONS: The CO2 challenge procedure appears to be a good dissection tool in the understanding of different subtypes of panic disorder. Moreover, there may be a more specific association with prominent respiratory symptom subtype and CO2 hypersensitivity.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10327907     DOI: 10.1176/ajp.156.5.739

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  14 in total

Review 1.  Obstructive sleep apnea and severe mental illness: evolution and consequences.

Authors:  Wei-Chen Lin; John W Winkelman
Journal:  Curr Psychiatry Rep       Date:  2012-10       Impact factor: 5.285

Review 2.  Hyperventilation in panic disorder and asthma: empirical evidence and clinical strategies.

Authors:  Alicia E Meuret; Thomas Ritz
Journal:  Int J Psychophysiol       Date:  2010-05-25       Impact factor: 2.997

3.  Temporal stability of multiple response systems to 7.5% carbon dioxide challenge.

Authors:  Roxann Roberson-Nay; Eugenia I Gorlin; Jessica R Beadel; Therese Cash; Scott Vrana; Bethany A Teachman
Journal:  Biol Psychol       Date:  2017-02-02       Impact factor: 3.251

4.  Panic disorder among Cambodian refugees attending a psychiatric clinic. Prevalence and subtypes.

Authors:  D Hinton; P Ba; S Peou; K Um
Journal:  Gen Hosp Psychiatry       Date:  2000 Nov-Dec       Impact factor: 3.238

Review 5.  Panic, suffocation false alarms, separation anxiety and endogenous opioids.

Authors:  Maurice Preter; Donald F Klein
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2007-08-09       Impact factor: 5.067

6.  Examining the latent class structure of CO2 hypersensitivity using time course trajectories of panic response systems.

Authors:  Roxann Roberson-Nay; Jessica R Beadel; Eugenia I Gorlin; Shawn J Latendresse; Bethany A Teachman
Journal:  J Behav Ther Exp Psychiatry       Date:  2014-11-15

7.  Panic disorder subtypes: deceptive somatic impersonators.

Authors:  Randy A Sansone; Lori A Sansone
Journal:  Psychiatry (Edgmont)       Date:  2009-08

8.  Cost-effectiveness analysis of an occupational therapy-led lifestyle approach and routine general practitioner's care for panic disorder.

Authors:  Rodney A Lambert; Paula Lorgelly; Ian Harvey; Fiona Poland
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2009-08-18       Impact factor: 4.328

9.  A factor analytic study of panic symptoms.

Authors:  Iby Neerakal; K Srinivasan
Journal:  Indian J Psychiatry       Date:  2002-04       Impact factor: 1.759

10.  Clinical characteristics of the respiratory subtype in panic disorder patients.

Authors:  Hye-Min Song; Ji-Hae Kim; Jung-Yoon Heo; Bum-Hee Yu
Journal:  Psychiatry Investig       Date:  2014-10-20       Impact factor: 2.505

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.